Join the Renal Failure group to help and get support from people like you.
Renal Failure News (Page 4)
Related terms: Acute Kidney Failure, Acute Renal Failure, Chronic Renal Failure, Kidney Failure, CRF
Similar Management Seen for Dialysis-Requiring AKI, ESKD Patients
THURSDAY, Oct. 5, 2023 – Patients with dialysis-requiring acute kidney injury (AKI-D) are prescribed the same dialysis as end-stage kidney disease (ESKD) patients, but some AKI-D patients have the...
Your Wrist Could Give Clues to Future Health
MONDAY, Sept. 25, 2023 – One day, it may be possible to monitor people for risk of disease through continuously measuring skin temperature. Researchers have found in a new study that wrist...
Benefit of ICD Attenuated in CKD Patients Receiving Cardiac Resynchronization
MONDAY, Sept. 25, 2023 – For patients with advanced chronic kidney disease (CKD) receiving cardiac resynchronization therapy (CRT), the benefit of an implantable cardioverter defibrillator (ICD) may...
FDA Approves Soaanz (torsemide) for Edema Treatment in Patients with Heart Failure and Renal Disease
VIENNA, VA. (PRWEB) JUNE 21, 2021 Sarfez Pharmaceuticals announced today approval by the U.S. Food and Drug Administration (FDA) of the Virginia-based company’s New Drug Application for Soaanz, a o...
FDA Approves Jynarque (tolvaptan) to Slow Kidney Function Decline in Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease
April 24, 2018 – TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has approved Jynarque (tolvaptan) as the first drug...
FDA Approves Amgen's Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis
THOUSAND OAKS, Calif., Feb. 7, 2017 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv (etelcalcetide) for the treatment of...
Baxter Receives FDA Approval for Phoxillum Solution for Electrolyte Management During Continuous Renal Replacement Therapy
DEERFIELD, Ill., (January 20, 2015) - Baxter International Inc. (NYSE:BAX) today announced the United States Food and Drug Administration (FDA) has approved Phoxillum Renal Replacement Solutions...
FDA Medwatch Alert: Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
ISSUE: Pentec Health, Inc. initiated a limited, voluntary recall of in-date nutritional prescriptions for renal patients due to lack of sterility assurance associated with one of its laminar flow...